thames medical lectures limited
thames medical lectures limited Company Information
Company Number
08019969
Registered Address
international house, 36-38 cornhill, london, EC3V 3NG
Industry
First-degree level higher education
Telephone
08450542460
Next Accounts Due
June 2025
Group Structure
View All
Shareholders
ursula benjamin & philip benjamin 100%
thames medical lectures limited Estimated Valuation
Pomanda estimates the enterprise value of THAMES MEDICAL LECTURES LIMITED at £917.5k based on a Turnover of £1.5m and 0.6x industry multiple (adjusted for size and gross margin).
thames medical lectures limited Estimated Valuation
Pomanda estimates the enterprise value of THAMES MEDICAL LECTURES LIMITED at £1.7m based on an EBITDA of £616k and a 2.82x industry multiple (adjusted for size and gross margin).
thames medical lectures limited Estimated Valuation
Pomanda estimates the enterprise value of THAMES MEDICAL LECTURES LIMITED at £1.3m based on Net Assets of £648.3k and 2.06x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Thames Medical Lectures Limited Overview
Thames Medical Lectures Limited is a live company located in london, EC3V 3NG with a Companies House number of 08019969. It operates in the first-degree level higher education sector, SIC Code 85421. Founded in April 2012, it's largest shareholder is ursula benjamin & philip benjamin with a 100% stake. Thames Medical Lectures Limited is a established, small sized company, Pomanda has estimated its turnover at £1.5m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Thames Medical Lectures Limited Health Check
Pomanda's financial health check has awarded Thames Medical Lectures Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
5 Weak
Size
annual sales of £1.5m, make it smaller than the average company (£3.2m)
- Thames Medical Lectures Limited
£3.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 78%, show it is growing at a faster rate (5.6%)
- Thames Medical Lectures Limited
5.6% - Industry AVG
Production
with a gross margin of 28.2%, this company has a higher cost of product (50.6%)
- Thames Medical Lectures Limited
50.6% - Industry AVG
Profitability
an operating margin of 40.5% make it more profitable than the average company (8.9%)
- Thames Medical Lectures Limited
8.9% - Industry AVG
Employees
with 3 employees, this is below the industry average (46)
3 - Thames Medical Lectures Limited
46 - Industry AVG
Pay Structure
on an average salary of £39.1k, the company has an equivalent pay structure (£39.1k)
- Thames Medical Lectures Limited
£39.1k - Industry AVG
Efficiency
resulting in sales per employee of £506.5k, this is more efficient (£91.8k)
- Thames Medical Lectures Limited
£91.8k - Industry AVG
Debtor Days
it gets paid by customers after 176 days, this is later than average (18 days)
- Thames Medical Lectures Limited
18 days - Industry AVG
Creditor Days
its suppliers are paid after 44 days, this is quicker than average (50 days)
- Thames Medical Lectures Limited
50 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Thames Medical Lectures Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Thames Medical Lectures Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 16.9%, this is a lower level of debt than the average (38.4%)
16.9% - Thames Medical Lectures Limited
38.4% - Industry AVG
THAMES MEDICAL LECTURES LIMITED financials
Thames Medical Lectures Limited's latest turnover from September 2023 is estimated at £1.5 million and the company has net assets of £648.3 thousand. According to their latest financial statements, Thames Medical Lectures Limited has 3 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 73,586 | 69,862 | |||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | 0 | 0 | |||||||||
| Interest Receivable | 0 | 0 | |||||||||
| Pre-Tax Profit | 16,633 | 20,480 | |||||||||
| Tax | -3,409 | -4,058 | |||||||||
| Profit After Tax | 13,224 | 16,422 | |||||||||
| Dividends Paid | 0 | 0 | |||||||||
| Retained Profit | 13,224 | 16,422 | |||||||||
| Employee Costs | 15,600 | 10,180 | |||||||||
| Number Of Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 45,289 | 6,488 | 2,012 | 1 | 116 | 2 | 482 | 151 | 1,001 | 56 | 186 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 45,289 | 6,488 | 2,012 | 1 | 116 | 2 | 482 | 151 | 1,001 | 56 | 186 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 734,638 | 211,202 | 112,240 | 60,183 | 33,514 | 38,439 | 45,279 | 39,539 | 14,604 | 75,242 | 1 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14,370 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 734,638 | 211,202 | 112,240 | 60,183 | 33,514 | 38,439 | 45,279 | 39,539 | 14,604 | 75,242 | 14,371 |
| total assets | 779,927 | 217,690 | 114,252 | 60,184 | 33,630 | 38,441 | 45,761 | 39,690 | 15,605 | 75,298 | 14,557 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 131,671 | 31,409 | 21,477 | 18,212 | 13,903 | 14,195 | 19,968 | 21,457 | 14,906 | 67,651 | 14,135 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 131,671 | 31,409 | 21,477 | 18,212 | 13,903 | 14,195 | 19,968 | 21,457 | 14,906 | 67,651 | 14,135 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 131,671 | 31,409 | 21,477 | 18,212 | 13,903 | 14,195 | 19,968 | 21,457 | 14,906 | 67,651 | 14,135 |
| net assets | 648,256 | 186,281 | 92,775 | 41,972 | 19,727 | 24,246 | 25,793 | 18,233 | 699 | 7,647 | 422 |
| total shareholders funds | 648,256 | 186,281 | 92,775 | 41,972 | 19,727 | 24,246 | 25,793 | 18,233 | 699 | 7,647 | 422 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 546 | ||||||||||
| Amortisation | 0 | ||||||||||
| Tax | -3,409 | -4,058 | |||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 523,436 | 98,962 | 52,057 | 26,669 | -4,925 | -6,840 | 5,740 | 24,935 | -60,638 | 75,241 | 1 |
| Creditors | 100,262 | 9,932 | 3,265 | 4,309 | -292 | -5,773 | -1,489 | 6,551 | -52,745 | 53,516 | 14,135 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | 0 | 0 | |||||||||
| cash flow from financing | -5,999 | -16,000 | |||||||||
| cash and cash equivalents | |||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,370 | 14,370 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,370 | 14,370 |
thames medical lectures limited Credit Report and Business Information
Thames Medical Lectures Limited Competitor Analysis
Perform a competitor analysis for thames medical lectures limited by selecting its closest rivals, whether from the EDUCATION sector, other small companies, companies in EC3V area or any other competitors across 12 key performance metrics.
thames medical lectures limited Ownership
THAMES MEDICAL LECTURES LIMITED group structure
Thames Medical Lectures Limited has no subsidiary companies.
Ultimate parent company
THAMES MEDICAL LECTURES LIMITED
08019969
thames medical lectures limited directors
Thames Medical Lectures Limited currently has 2 directors. The longest serving directors include Mr Philip Benjamin (May 2012) and Mrs Ursula Benjamin (May 2012).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Philip Benjamin | England | 59 years | May 2012 | - | Director |
| Mrs Ursula Benjamin | England | 61 years | May 2012 | - | Director |
P&L
September 2023turnover
1.5m
+214%
operating profit
616k
0%
gross margin
28.2%
+27.8%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
648.3k
+2.48%
total assets
779.9k
+2.58%
cash
0
0%
net assets
Total assets minus all liabilities
thames medical lectures limited company details
company number
08019969
Type
Private limited with Share Capital
industry
85421 - First-degree level higher education
incorporation date
April 2012
age
12
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
September 2023
previous names
thames medical college limited (September 2014)
thames medical lectures limited (July 2014)
accountant
-
auditor
-
address
international house, 36-38 cornhill, london, EC3V 3NG
Bank
-
Legal Advisor
-
thames medical lectures limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to thames medical lectures limited.
thames medical lectures limited Companies House Filings - See Documents
| date | description | view/download |
|---|
